SUNNYVALE, Calif., Aug. 22 Cepheid(Nasdaq: CPHD) today announced that its executives will be speaking at thefollowing investor conferences, and invited investors to participate viawebcast.
To access the live webcasts for these events, please visit Cepheid'swebsite at http://www.cepheid.com/investors at least 15 minutes before theschedule start time to download any necessary audio or plug-in software. Areplay of the webcast will be available shortly following the presentation andwill remain available for at least 90 days.
Cepheid (Nasdaq: CPHD), based in Sunnyvale, Calif., is an on-demandmolecular diagnostics company that develops, manufactures, and marketsfully-integrated systems and tests for genetic analysis in the clinical,industrial and biothreat markets. The Company's systems enable rapid,sophisticated genetic testing for organisms and genetic-based diseases byautomating otherwise complex manual laboratory procedures. Cepheid'seasy-to-use systems integrate a number of complicated and time-intensivesteps, including sample preparation, DNA amplification and detection, whichenable the analysis of complex biological samples in its proprietary testcartridges. Through its strong molecular biology capabilities, the Company isfocusing on those applications where rapid molecular testing is particularlyimportant, such as identifying infectious disease and cancer in the clinicalmarket; food, agricultural, and environmental testing in the industrialmarket; and identifying bio-terrorism agents in the biothreat market.Thomas Weisel Partners Healthcare Conference, Boston, MA Wednesday, September 3, 2008 at 2.05 p.m. Eastern Time R.W. Baird Small Cap Healthcare Conference, New York, NY Wednesday, September 10, 2008 at 9.00 a.m. Eastern Time UBS Global Life Sciences Conference, New York, NY Tuesday, September 23, 2008 at 9.00 a.m. Eastern Time